Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of a single-use IVUS-guided ablation device for essential hypertension; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVUS ablation device (single-use) (intravascular ultrasound-guided ablation device)

Snippet

Sponsor: Lepu Medical Technology (Beijing) Co., Ltd. | Conditions: Essential Hypertension | NA | Status: RECRUITING